(Medical Xpress)—A dollop of peanut butter and a ruler can be used to confirm a diagnosis of early stage Alzheimer's disease, University of Florida Health researchers have found.
Jennifer Stamps, a graduate student in the UF McKnight Brain Institute Center for Smell and Taste, and her colleagues reported the findings of a small pilot study in the Journal of the Neurological Sciences.
Stamps came up with the idea of using peanut butter to test for smell sensitivity while she was working with Dr. Kenneth Heilman, the James E. Rooks distinguished professor of neurology and health psychology in the UF College of Medicine's department of neurology.
She noticed while shadowing in Heilman's clinic that patients were not tested for their sense of smell. The ability to smell is associated with the first cranial nerve and is often one of the first things to be affected in cognitive decline. Stamps also had been working in the laboratory of Linda Bartoshuk, the William P. Bushnell presidentially endowed professor in the College of Dentistry's department of community dentistry and behavioral sciences and director of human research in the Center for Smell and Taste.
"Dr. Heilman said, 'If you can come up with something quick and inexpensive, we can do it,'" Stamps said.
She thought of peanut butter because, she said, it is a "pure odorant" that is only detected by the olfactory nerve and is easy to access.
In the study, patients who were coming to the clinic for testing also sat down with a clinician, 14 grams of peanut butter—which equals about one tablespoon—and a metric ruler. The patient closed his or her eyes and mouth and blocked one nostril. The clinician opened the peanut butter container and held the ruler next to the open nostril while the patient breathed normally. The clinician then moved the peanut butter up the ruler one centimeter at a time during the patient's exhale until the person could detect an odor. The distance was recorded and the procedure repeated on the other nostril after a 90-second delay.
The clinicians running the test did not know the patients' diagnoses, which were not usually confirmed until weeks after the initial clinical testing.
The scientists found that patients in the early stages of Alzheimer's disease had a dramatic difference in detecting odor between the left and right nostril—the left nostril was impaired and did not detect the smell until it was an average of 10 centimeters closer to the nose than the right nostril had made the detection in patients with Alzheimer's disease. This was not the case in patients with other kinds of dementia; instead, these patients had either no differences in odor detection between nostrils or the right nostril was worse at detecting odor than the left one.
Of the 24 patients tested who had mild cognitive impairment, which sometimes signals Alzheimer's disease and sometimes turns out to be something else, about 10 patients showed a left nostril impairment and 14 patients did not. The researchers said more studies must be conducted to fully understand the implications.
"At the moment, we can use this test to confirm diagnosis," Stamps said. "But we plan to study patients with mild cognitive impairment to see if this test might be used to predict which patients are going to get Alzheimer's disease."
Stamps and Heilman point out that this test could be used by clinics that don't have access to the personnel or equipment to run other, more elaborate tests required for a specific diagnosis, which can lead to targeted treatment. At UF Health, the peanut butter test will be one more tool to add to a full suite of clinical tests for neurological function in patients with memory disorders.
One of the first places in the brain to degenerate in people with Alzheimer's disease is the front part of the temporal lobe that evolved from the smell system, and this portion of the brain is involved in forming new memories.
"We see people with all kinds of memory disorders," Heilman said. Many tests to confirm a diagnosis of Alzheimer's disease or other dementias can be time-consuming, costly or invasive. "This can become an important part of the evaluation process."
Explore further: Scientists spot early signs of Alzheimer's disease
Medical Xpress on facebook
Related Stories
Scientists spot early signs of Alzheimer's disease
Jul 09, 2013
Early signs of Alzheimer's disease can be detected years before diagnosis, according to researchers at Birmingham City University.
Girls who eat peanut butter may improve breast health later in life
Sep 26, 2013
(Medical Xpress)—Here's some news worth spreading: Girls who eat more peanut butter could improve their breast health later in life.
Seizures late in life may be an early sign of Alzheimer's disease
Jul 08, 2013
Patients with epilepsy who had amnestic mild cognitive impairment (aMCI) or Alzheimer disease (AD) presented earlier with cognitive decline than patients who did not have epilepsy, according to a report published by JAMA Ne ...
Toward an early diagnostic tool for Alzheimer's disease
Aug 29, 2013
Despite all the research done on Alzheimer's, there is still no early diagnostic tool for the disease. By looking at the brain wave components of individuals with the disease, Professor Tiago H. Falk of INRS's Centre Énergie ...
Mayo study seeks to pretreat Alzheimer's in effort to prevent brain damage
Jul 16, 2013
The day is coming when doctors will be able to diagnose and treat Alzheimer's disease before people have symptoms, and Ronald Petersen is among the doctors laying the groundwork for that future.
Recommended for you
A potential new strategy to face dementia
20 hours ago
Alzheimer's disease (AD) affects millions of people worldwide. As a result of an increase in life expectancy, the number of patients with dementia is expected to increase dramatically. Due to the lack of effective treatments ...
Novel accelerometer-based algorithm detects early signals of AD in everyday motion behavior
Oct 07, 2013
The projected substantial increase in Alzheimer's disease due to the higher life expectancy in modern societies is one of the great future challenges of health care systems worldwide. Alzheimer's disease leads to significant ...
Epigenetic markers shows promise in Alzheimer's disease
Oct 07, 2013
Increasing evidence suggests that epigenetic regulation is associated with the pathogenesis of Alzheimer's disease (AD) and targeting it may one day lead to novel diagnostic and therapeutic strategies, research suggests.
Creative app for dementia careworkers
Oct 04, 2013
Dementia is an ageing-related condition affecting mental acuity and memory. Incidence doubles in a population for every five years over the age of 65 years, so that almost one fifth of those living to 85 ...
Researchers find potential link between gum disease and Alzheimer's
Oct 04, 2013
(Medical Xpress)—Oral bacteria from poor dental hygiene have been linked to brain tissue degeneration, according to new evidence from an international team of researchers, including one at the University of Florida College ...
Key cellular auto-cleaning mechanism mediates the formation of plaques in Alzheimer's brain
Oct 03, 2013
Autophagy, a key cellular auto-cleaning mechanism, mediates the formation of amyloid beta plaques, one of the hallmarks of Alzheimer's disease. It might be a potential drug target for the treatment of the ...
User comments
© Medical Xpress 2011-2013, Phys.org network
(Medical Xpress)—A dollop of peanut butter and a ruler can be used to confirm a diagnosis of early stage Alzheimer's disease, University of Florida Health researchers have found.
Jennifer Stamps, a graduate student in the UF McKnight Brain Institute Center for Smell and Taste, and her colleagues reported the findings of a small pilot study in the Journal of the Neurological Sciences.
Stamps came up with the idea of using peanut butter to test for smell sensitivity while she was working with Dr. Kenneth Heilman, the James E. Rooks distinguished professor of neurology and health psychology in the UF College of Medicine's department of neurology.
She noticed while shadowing in Heilman's clinic that patients were not tested for their sense of smell. The ability to smell is associated with the first cranial nerve and is often one of the first things to be affected in cognitive decline. Stamps also had been working in the laboratory of Linda Bartoshuk, the William P. Bushnell presidentially endowed professor in the College of Dentistry's department of community dentistry and behavioral sciences and director of human research in the Center for Smell and Taste.
"Dr. Heilman said, 'If you can come up with something quick and inexpensive, we can do it,'" Stamps said.
She thought of peanut butter because, she said, it is a "pure odorant" that is only detected by the olfactory nerve and is easy to access.
In the study, patients who were coming to the clinic for testing also sat down with a clinician, 14 grams of peanut butter—which equals about one tablespoon—and a metric ruler. The patient closed his or her eyes and mouth and blocked one nostril. The clinician opened the peanut butter container and held the ruler next to the open nostril while the patient breathed normally. The clinician then moved the peanut butter up the ruler one centimeter at a time during the patient's exhale until the person could detect an odor. The distance was recorded and the procedure repeated on the other nostril after a 90-second delay.
The clinicians running the test did not know the patients' diagnoses, which were not usually confirmed until weeks after the initial clinical testing.
The scientists found that patients in the early stages of Alzheimer's disease had a dramatic difference in detecting odor between the left and right nostril—the left nostril was impaired and did not detect the smell until it was an average of 10 centimeters closer to the nose than the right nostril had made the detection in patients with Alzheimer's disease. This was not the case in patients with other kinds of dementia; instead, these patients had either no differences in odor detection between nostrils or the right nostril was worse at detecting odor than the left one.
Of the 24 patients tested who had mild cognitive impairment, which sometimes signals Alzheimer's disease and sometimes turns out to be something else, about 10 patients showed a left nostril impairment and 14 patients did not. The researchers said more studies must be conducted to fully understand the implications.
"At the moment, we can use this test to confirm diagnosis," Stamps said. "But we plan to study patients with mild cognitive impairment to see if this test might be used to predict which patients are going to get Alzheimer's disease."
Stamps and Heilman point out that this test could be used by clinics that don't have access to the personnel or equipment to run other, more elaborate tests required for a specific diagnosis, which can lead to targeted treatment. At UF Health, the peanut butter test will be one more tool to add to a full suite of clinical tests for neurological function in patients with memory disorders.
One of the first places in the brain to degenerate in people with Alzheimer's disease is the front part of the temporal lobe that evolved from the smell system, and this portion of the brain is involved in forming new memories.
"We see people with all kinds of memory disorders," Heilman said. Many tests to confirm a diagnosis of Alzheimer's disease or other dementias can be time-consuming, costly or invasive. "This can become an important part of the evaluation process."
Explore further: Scientists spot early signs of Alzheimer's disease
Medical Xpress on facebook
Related Stories
Scientists spot early signs of Alzheimer's disease
Jul 09, 2013
Early signs of Alzheimer's disease can be detected years before diagnosis, according to researchers at Birmingham City University.
Girls who eat peanut butter may improve breast health later in life
Sep 26, 2013
(Medical Xpress)—Here's some news worth spreading: Girls who eat more peanut butter could improve their breast health later in life.
Seizures late in life may be an early sign of Alzheimer's disease
Jul 08, 2013
Patients with epilepsy who had amnestic mild cognitive impairment (aMCI) or Alzheimer disease (AD) presented earlier with cognitive decline than patients who did not have epilepsy, according to a report published by JAMA Ne ...
Toward an early diagnostic tool for Alzheimer's disease
Aug 29, 2013
Despite all the research done on Alzheimer's, there is still no early diagnostic tool for the disease. By looking at the brain wave components of individuals with the disease, Professor Tiago H. Falk of INRS's Centre Énergie ...
Mayo study seeks to pretreat Alzheimer's in effort to prevent brain damage
Jul 16, 2013
The day is coming when doctors will be able to diagnose and treat Alzheimer's disease before people have symptoms, and Ronald Petersen is among the doctors laying the groundwork for that future.
Recommended for you
A potential new strategy to face dementia
20 hours ago
Alzheimer's disease (AD) affects millions of people worldwide. As a result of an increase in life expectancy, the number of patients with dementia is expected to increase dramatically. Due to the lack of effective treatments ...
Novel accelerometer-based algorithm detects early signals of AD in everyday motion behavior
Oct 07, 2013
The projected substantial increase in Alzheimer's disease due to the higher life expectancy in modern societies is one of the great future challenges of health care systems worldwide. Alzheimer's disease leads to significant ...
Epigenetic markers shows promise in Alzheimer's disease
Oct 07, 2013
Increasing evidence suggests that epigenetic regulation is associated with the pathogenesis of Alzheimer's disease (AD) and targeting it may one day lead to novel diagnostic and therapeutic strategies, research suggests.
Creative app for dementia careworkers
Oct 04, 2013
Dementia is an ageing-related condition affecting mental acuity and memory. Incidence doubles in a population for every five years over the age of 65 years, so that almost one fifth of those living to 85 ...
Researchers find potential link between gum disease and Alzheimer's
Oct 04, 2013
(Medical Xpress)—Oral bacteria from poor dental hygiene have been linked to brain tissue degeneration, according to new evidence from an international team of researchers, including one at the University of Florida College ...
Key cellular auto-cleaning mechanism mediates the formation of plaques in Alzheimer's brain
Oct 03, 2013
Autophagy, a key cellular auto-cleaning mechanism, mediates the formation of amyloid beta plaques, one of the hallmarks of Alzheimer's disease. It might be a potential drug target for the treatment of the ...
User comments
© Medical Xpress 2011-2013, Phys.org network
0 comments:
Post a Comment